Profiel
Lida Pacaud is currently Chief Executive & Medical Officer at Ichnos Glenmark Innovation, Inc. starting in 2025.
Formerly, Dr. Pacaud was Vice President-Clinical Development at Legend Biotech Corp.
from 2021 to 2023 and Head-Global Clinical Program at Novartis International AG from 2013 to 2021.
Education includes a doctorate from Tbilisi State Medical University.
Actieve functies van Lida Pacaud
| Bedrijven | Functie | Begin |
|---|---|---|
Ichnos Sciences, Inc.
Ichnos Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops biologics in oncology | Algemeen Directeur | 06-12-2025 |
Eerdere bekende functies van Lida Pacaud
| Bedrijven | Functie | Einde |
|---|---|---|
| LEGEND BIOTECH CORPORATION | Hoofd Techniek/Wetenschap/O&O | 01-06-2023 |
Novartis International AG
Novartis International AG Pharmaceuticals: MajorHealth Technology Offers healthcare solutions | Corporate Officer/Principal | 01-01-2021 |
Opleiding van Lida Pacaud
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Novartis International AG
Novartis International AG Pharmaceuticals: MajorHealth Technology Offers healthcare solutions | Health Technology |
Legend Biotech Corp.
Legend Biotech Corp. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which engages in the discovery and development of novel cell therapies for oncology | Health Technology |
Ichnos Sciences, Inc.
Ichnos Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops biologics in oncology | Health Technology |
Tbilisi State Medical University
Tbilisi State Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















